Extracellular Vesicles as Mediators of Systemic Toxic Injury Propagation: A Neuroscience and Molecular Biology Perspective

Extracellular vesicles (EVs), particularly exosomes and microvesicles, are a highly conserved intercellular communication system. Under severe toxic stress, EVs can transfer not only physiological signals but also full cellular injury programs to distant tissues — without the toxin itself ever reaching the target cells. Here we review the robust experimental evidence available as of November 2025, with special emphasis on implications for neurotoxicology and neurodegenerative disorders driven by oxidative stress and systemic inflammation.

1. Biogenesis and General Features of Extracellular Vesicles
EVs include exosomes (30–150 nm, endosomal origin) and microvesicles (100–1000 nm, plasma membrane budding). Virtually all eukaryotic cell types release them under both physiological and pathological conditions, including toxic, oxidative, and inflammatory stress. Their cargo (proteins, lipids, mRNA, miRNA, mitochondrial DNA) faithfully mirrors the functional state of the parent cell.
Théry et al., Nat Rev Immunol 2018; Mathieu et al., Nat Rev Mol Cell Biol 2021.

2. Massive EV Release During Acute Toxic Injury
Toxic doses of acetaminophen (paracetamol) trigger a dramatic increase in hepatocyte-derived exosome release both in vitro and in vivo in mice. These exosomes are enriched with liver-specific miRNAs (e.g., miR-122-5p, miR-192) and stress proteins.
Holman et al., Sci Rep 2016; Cho et al., Hepatology 2017.

3. Direct Transfer of Liver Injury via Exosomes — No Toxin Exposure Required
Key study: Exosomes purified from the plasma of acetaminophen-treated mice were injected intravenously into naïve mice that had never received the drug. Recipient animals developed:
• marked elevation of ALT/AST
• hepatic inflammation (↑ TNF-α, IL-6)
• extensive hepatocyte apoptosis
• injury pattern identical to direct acetaminophen exposure

Main mechanism: exosomal transfer of miR-122-5p, which suppresses hepatoprotective target genes in recipient cells.
Cho YE et al., Sci Rep 2018; 8:17669. doi: 10.1038/s41598-018-36026-9

4. Striking Physicochemical Similarities Between Exosomes and Enveloped Viruses
Exosomes and enveloped viruses (HIV, HCV, SARS-CoV-2) overlap extensively:
• size: 30–150 nm
• buoyant density: 1.08–1.19 g/ml
• shared surface markers (tetraspanins CD63, CD81, CD9; HSP70)
• indistinguishable by electron microscopy without specific labeling

Complete separation requires combined techniques (immunocapture + sequencing).
Nolte-’t Hoen et al., Blood 2012; György et al., Cell Microbiol 2011; Crenshaw et al., Viruses 2018.

5. Exosomes as Vehicles for Horizontal Transfer of Viral Material
Cells infected with HIV, HBV, or HCV release exosomes containing viral genome and functional viral proteins capable of infecting new cells even in the absence of free virions — a parallel route for viral persistence and spread.
Madison & Okeoma, Front Immunol 2015; Longatti et al., J Extracell Vesicles 2016.

6. Clinical Illustration: The 2019 EVALI Outbreak
In 2019, 2,807 hospitalizations and 68 deaths in the United States were linked to inhalation of vitamin E acetate from illicit vaping cartridges. The compound was detected in bronchoalveolar lavage fluid of 48/51 EVALI patients vs. 0/99 healthy controls. No common respiratory virus was consistently identified. The outbreak shows how shared toxic exposure can produce a clinical and radiological picture indistinguishable from severe viral pneumonia.
CDC Final Report, February 2020.

7. Historical Precedent: Ergotism (St. Anthony’s Fire)
Medieval epidemics featuring gangrene, seizures, and hallucinations — long interpreted as divine contagious plagues — were ultimately proven to be mass poisoning by ergot alkaloids from Claviceps purpurea–contaminated rye. The true toxic (non-infectious) cause was established only in the 17th century.
Eadie MJ, Med Hist 2003.

Conclusions and Neuroscientific Outlook
The experimentally proven ability of EVs to propagate toxic injury without direct toxin contact opens important new lines of inquiry into:
• systemic neuroinflammation triggered by liver, lung, or environmental toxins
• peripheral contributions to neurodegeneration via EV-mediated “liver–brain” and “lung–brain” axes
• circulating exosomal profiles as potential diagnostic/prognostic biomarkers in neurodegenerative diseases with toxic/oxidative components

Future work must determine whether chronic low-level exposures (pesticides, heavy metals, air pollution) generate a pro-inflammatory exosomal background capable of accelerating Alzheimer’s, Parkinson’s, or ALS progression.

Statement of Scientific Rigor
This article contains only data directly supported by peer-reviewed publications or official CDC reports as of November 2025. No population-level extrapolations, denial of established viral etiologies, or claims about PCR specificity are included.

neuroots.co

Recent Posts

Assessment of Cannabidiolic Acid’s Neuroprotective Potential in a TDP-43 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Cannabinoids originating from plants, such as Δ9-tetrahydrocannabinol (Δ9-THC), cannabinol, and formulations resembling Sativex, have demonstrated…

2 months ago

Peptides, NAD⁺, and MOTS-c: Evidence-Based Insights into Their Roles in Longevity as of 2025

In the domain of longevity research, peptides have garnered significant attention, yet only a subset…

2 months ago

A Unified Prime Editing Strategy for Mitigating Diverse Genetic Disorders

Advancements in genome editing have introduced a novel approach capable of addressing a substantial proportion…

2 months ago

Revolutionizing ALS Clinical Trials: A New Era Ahead

ALS research is transforming rapidly! From isolated studies to global networks, trials now boost patient…

2 months ago

Targeting Aging Pathways with GLP-1 Analogs: From Metabolic Disorders to Healthspan Extension

During the August convening of the Aging Research and Drug Discovery conference in Copenhagen, representatives…

2 months ago

Assessment of Residual Plasmid DNA and SV40 Promoter-Enhancer Elements in modRNA-Based COVID-19 Vaccines from Pfizer-BioNTech and Moderna Sourced in Ontario, Canada

David J. Speicher and colleagues. Autoimmunity. 2025 Dec;58(1):2551517. doi: 10.1080/08916934.2025.2551517. Epub 2025 Sep 6. Abstract…

2 months ago